‘Digital life story’ tools are invaluable for memory care residents . . . but more need to know how...
By
Aaron Dorman
Mar 25, 2024
Giving older adults living with dementia digital tools to showcase their “life stories” is a tremendous addition to senior living and care communities, a new study shows.
Decision-making on antipsychotic medication use in assisted living needs system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic medications in assisted living/ residential care communities are based on attitudes, underlying morality and perceived expertise, requiring a system-level...
Get SMART: interactive whiteboard gives providers dynamic tool for engagement, socializing, developer...
By
Aaron Dorman
Feb 22, 2024
An interactive whiteboard developer is making its first foray into senior living and care spaces in the United States with a new pilot program in Colorado.
Act prioritizes fight against Alzheimer’s disease with state plan
By
Kimberly Bonvissuto
Sep 12, 2023
South Carolina’s adoption of a state Alzheimer’s plan is a “step forward,” according to senior living advocates.
Two Alzheimer’s drug trials halted
By
Lois A. Bowers
Mar 22, 2019
Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Providers identify 5 key areas for person-centered care of residents with dementia
By
Kimberly Bonvissuto
Nov 19, 2020
Several senior living companies were part of a roundtable that helped researchers identify five areas of change and developed person-centered practical solutions to address the unmet needs of people with...
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
We need to do better for people living with dementia
By
Rob Liebreich
Feb 26, 2024
With 97% of income for those with dementia going to care costs, we need to do better. Senior living and care should be the No. 1 force for change.